Home > Insider Trading > Filing (0001209191-22-033727)

Filing Details

Accession Number:: 0001209191-22-033727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-02 19:41:17
Reporting Period:: 2022-05-31

Accepted Time:: 2022-06-02 19:41:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1538210	Neximmune Inc.	NEXI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1247015	J Sol Barer	C/O Neximmune, Inc. 9119 Gaither Road Gaithersburg MD 20877		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-06-02	20,720	$2.22	1,617,814	No	4	P	Direct
Common Stock	Acquisiton	2022-06-01	40,000	$2.35	1,597,094	No	4	P	Direct
Common Stock	Acquisiton	2022-05-31	39,280	$2.19	1,557,094	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,538,013	Indirect	Held by B&S NexImmune Holdco LLC
Common Stock	346,577	Indirect	Held by Joshua Barer

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.09 to $2.35, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Excludes 175,012 shares of common stock underlying options that are currently exercisable.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.23 to $2.59, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.95 to $2.46, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Mr. Sol Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein.
Mr. Sol Barer is the father of Joshua Barer. Mr. Sol Barer disclaims beneficial ownership of the securities held by Joshua Barer except to the extent of his pecuniary interest therein.